Application Deadline: Saturday, March 15, 2025 at 11:55 PM EST.
Applications are now open for the 2025 AIM-HI Women’s Venture Competition. The 2025 AIM-HI Women’s Venture Competition is now open to women-led oncology companies worldwide! This online application is comprised of three parts: general information, a presentation summarizing a business plan, and a brief video delivered in easy-to-understand language for a general audience.
Requirements
- Women-led oncology companies seeking pre-seed, seed, and Series A investments are eligible to apply. The company must have a woman in senior leadership, who has an equity stake – could be Founder or C-level executive.
- The applying company must have technology ownership in place.
Selection Criteria
- All submitted applications will be reviewed and screened by our Selection Committee based on the quality of applications. 6-8 semi-finalists will be chosen around late April and invited to compete in front of a Judging Committee in June to select finalists who will be recognized and awarded honorariums and certificates.
Benefits
- The company that passes the due diligence process will receive up to $1 million in investment from AIM-HI and co-investors.
If the online application is not appearing in your browser below, please e-mail AIM-HI Program Manager Ella Ye at eye@aim-hiaccelerator.org to request a PDF version, and she will respond within 24 hours.
For More Information:
Visit the Official Webpage of the AIM-HI Women’s Venture Competition
